Diversified Trust Co Purchases 871 Shares of Cardinal Health, Inc. (NYSE:CAH)

Diversified Trust Co grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 24,591 shares of the company’s stock after acquiring an additional 871 shares during the quarter. Diversified Trust Co’s holdings in Cardinal Health were worth $2,418,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Clearstead Trust LLC bought a new stake in Cardinal Health in the 4th quarter valued at about $25,000. Raleigh Capital Management Inc. boosted its stake in shares of Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after buying an additional 268 shares during the period. YHB Investment Advisors Inc. bought a new stake in shares of Cardinal Health in the first quarter valued at approximately $32,000. LRI Investments LLC acquired a new stake in Cardinal Health during the first quarter worth approximately $32,000. Finally, Palisade Asset Management LLC bought a new position in Cardinal Health during the 1st quarter worth $34,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CAH shares. Argus cut their price objective on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research report on Wednesday, May 15th. Robert W. Baird boosted their price target on Cardinal Health from $129.00 to $130.00 and gave the stock an “outperform” rating in a report on Tuesday, July 9th. Evercore ISI decreased their price target on shares of Cardinal Health from $115.00 to $105.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th. Finally, Citigroup decreased their target price on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating on the stock in a research note on Friday, July 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $109.67.

Cardinal Health Stock Up 3.8 %

Shares of NYSE CAH traded up $3.92 during trading on Wednesday, reaching $106.50. The company had a trading volume of 730,068 shares, compared to its average volume of 2,123,667. The stock has a market cap of $25.94 billion, a PE ratio of 45.59, a P/E/G ratio of 1.14 and a beta of 0.61. Cardinal Health, Inc. has a 12-month low of $85.11 and a 12-month high of $116.04. The business’s 50-day moving average is $98.80 and its 200 day moving average is $103.15.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.12. The firm had revenue of $59.87 billion for the quarter, compared to the consensus estimate of $58.74 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The company’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.55 earnings per share. On average, analysts anticipate that Cardinal Health, Inc. will post 7.35 earnings per share for the current year.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.